Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025)

Aurora Cannabis (ACB) posted quarterly Cash from Investing Activities of -$979864.6 for Q1 2025, up 67.9% year-on-year from -$583608.4 in Q1 2024, and up 57.38% on a QoQ basis from -$2.3 million in Q4 2024.

Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Investing Activities for 9 consecutive years, with -$979864.6 the latest figure, recorded in Q1 2025.

  • Quarterly Cash from Investing Activities rose 67.9% year-over-year to -$979864.6 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$6.0 million (up 88.19% YoY) and the FY2026 annual result came in at -$52.7 million, down 517.41% from the prior year.
  • Cash from Investing Activities climbed to -$979864.6 in Q1 2025 per ACB's latest filing, from -$2.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ACB reached as high as $25.8 million in Q4 2021 and fell as low as -$62.6 million in Q3 2022.
  • A 5-year average of -$10.0 million and a median of -$2.7 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities soared 770.37% — and 2022, when it sank 324.38%.
  • Year by year, Cash from Investing Activities stood at $25.8 million in 2021, then tumbled by 291.45% to -$49.5 million in 2022, then soared by 110.22% to $5.1 million in 2023, then sank by 145.45% to -$2.3 million in 2024, then surged by 57.38% to -$979864.6 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$979864.6, -$2.3 million, and -$2.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.60 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 Aurora Cannabis 156.08 Mn 70.84 Mn 21.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -979,864.57
Mar 31, 2025 -979,864.57
Dec 31, 2024 -2.30 Mn
Dec 31, 2024 -2.30 Mn
Sep 30, 2024 -2.67 Mn
Sep 30, 2024 -2.67 Mn
Jun 30, 2024 -11,698.25
Jun 30, 2024 -11,698.25
Mar 31, 2024 -3.05 Mn
Mar 31, 2024 -3.05 Mn
Dec 31, 2023 5.06 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 -2.97 Mn
Sep 30, 2023 -2.97 Mn
Dec 31, 2022 -49.48 Mn
Dec 31, 2022 -49.48 Mn
Sep 30, 2022 -62.62 Mn
Sep 30, 2022 -62.62 Mn
Jun 30, 2022 -31.17 Mn
Jun 30, 2022 -31.17 Mn